Proathlete Wealth Management’s Avantis US Small Cap Value ETF AVUV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14M Sell
112,496
-1,464
-1% -$175K 3.47% 7
2026
Q1
$12.7M Buy
113,960
+2,769
+2% +$305K 3.51% 7
2025
Q4
$11.4M Buy
111,191
+6,424
+6% +$643K 3.1% 7
2025
Q3
$10.4M Buy
104,767
+5,745
+6% +$556K 3% 7
2025
Q2
$9.02M Buy
99,022
+7,437
+8% +$641K 2.87% 8
2025
Q1
$7.99M Buy
91,585
+8,396
+10% +$789K 2.91% 9
2024
Q4
$8.03M Buy
83,189
+7,718
+10% +$767K 3.02% 9
2024
Q3
$7.24M Buy
75,471
+6,249
+9% +$584K 2.98% 9
2024
Q2
$6.21M Buy
69,222
+66,958
+2,958% +$6.06M 2.94% 8
2024
Q1
$212K Buy
+2,264
New +$200K 0.11% 55

Other funds holding AVUV

Proathlete Wealth Management's AVUV Position: Q2 2026 in Review

Proathlete Wealth Management reduced its Avantis US Small Cap Value ETF (AVUV) stake by 1.3% in Q2 2026, selling an estimated $175K and leaving 112,496 shares worth $14M. The position accounts for 3.47% of the portfolio, ranked #7.

Proathlete Wealth Management first reported a position in AVUV in Q1 2024 and has held it in 10 quarters since. 1,142 funds tracked by Wall St. Rank hold AVUV as of Q2 2026.

  • Proathlete Wealth Management held 112,496 shares of Avantis US Small Cap Value ETF worth $14M as of Q2 2026.
  • Proathlete Wealth Management sold 1,464 Avantis US Small Cap Value ETF shares in Q2 2026, an estimated $175K.
  • Avantis US Small Cap Value ETF made up 3.47% of Proathlete Wealth Management's portfolio in Q2 2026, its #7 holding.
  • Proathlete Wealth Management first reported a position in Avantis US Small Cap Value ETF in Q1 2024 and has held it in 10 quarters since.
  • 1,142 funds tracked by Wall St. Rank held Avantis US Small Cap Value ETF as of Q2 2026.

Based on Proathlete Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.